Abiopharma

News list

Chen Ruoyu 🟢 acquired 50.0K shares (1 derivative) of GYRE THERAPEUTICS, INC. (GYRE) at $7.31 Transaction Date: Jan 07, 2026 | Filing ID: 000831

Full text

News bot Jan. 9, 2026, 9:04 p.m.
🔍 Chen Ruoyu (Executive)

Company: GYRE THERAPEUTICS, INC. (GYRE)

Report Date: 2026-01-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 50,000
Detailed Transactions and Holdings:
- Acquired 50,000 shares of Stock Option (Right to Buy) at $7.31 per share (Derivative)
  Date: 2026-01-07 | Code: A | Expires: 2036-01-07 | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option represents a right to purchase a total of 50,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.